Orthofix Expects COVID Headwinds Through Second Quarter

By Mike Evers

Orthofix Expects COVID Headwinds Through Second Quarter
The company grew less than 1% in 1Q21, driven by its M-6 disc and interbody portfolio. Orthofix sees COVID headwinds lasting through 1H21.

Member-Only Content

SUBSCRIBE Login

Product Labels: Spine Artificial Disc, Lower Extremity

Tags: Revenue Report